Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Dose Finding of Xigris in ESRD Hemodialysis
NCT01227187Phase 2Completed
- Sponsor
- George Washington University
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of drotrecogin alfa in end stage renal disease (ESRD), sponsored by George Washington University. Started Oct 2008; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01227187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227187.